179 related articles for article (PubMed ID: 21242770)
1. Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis.
Munir F; Kalawsky K; Lawrence C; Yarker J; Haslam C; Ahmed S
Cancer Nurs; 2011; 34(5):385-92. PubMed ID: 21242770
[TBL] [Abstract][Full Text] [Related]
2. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
[TBL] [Abstract][Full Text] [Related]
3. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
4. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
5. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
7. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
8. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
Hurria A; Goldfarb S; Rosen C; Holland J; Zuckerman E; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Robson M; Currie VE; Theodoulou M; Norton L; Hudis C
Breast Cancer Res Treat; 2006 Aug; 98(3):343-8. PubMed ID: 16541322
[TBL] [Abstract][Full Text] [Related]
9. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
[TBL] [Abstract][Full Text] [Related]
10. Domains of distress: the experience of breast cancer in Australia.
Steginga S; Occhipinti S; Wilson K; Dunn J
Oncol Nurs Forum; 1998 Jul; 25(6):1063-70. PubMed ID: 9679264
[TBL] [Abstract][Full Text] [Related]
11. Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients.
Beisecker A; Cook MR; Ashworth J; Hayes J; Brecheisen M; Helmig L; Hyland S; Selenke D
Psychooncology; 1997 Jun; 6(2):85-93. PubMed ID: 9205966
[TBL] [Abstract][Full Text] [Related]
12. Fatigue in patients undergoing chemotherapy, their self-care and the role of health professionals: a qualitative study.
Spichiger E; Rieder E; Müller-Fröhlich C; Kesselring A
Eur J Oncol Nurs; 2012 Apr; 16(2):165-71. PubMed ID: 21624847
[TBL] [Abstract][Full Text] [Related]
13. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
14. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
16. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
Paraska K; Bender CM
Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
[TBL] [Abstract][Full Text] [Related]
17. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
McInnes JA; Knobf MT
Oncol Nurs Forum; 2001 May; 28(4):675-84. PubMed ID: 11383182
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
20. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.
Rahi JS; Manaras I; Tuomainen H; Hundt GL
Pediatrics; 2004 Oct; 114(4):e477-82. PubMed ID: 15466074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
